CSIMarket Company Name, Ticker, Customers, else..
 
Precipio inc   (NASDAQ: PRPO)
Other Ticker:  
 
 
Price: $7.8199 $0.66 9.216%
Day's High: $7.8199 Week Perf: 5.82 %
Day's Low: $ 6.54 30 Day Perf: 5.93 %
Volume (M): 2 52 Wk High: $ 10.74
Volume (M$): $ 14 52 Wk Avg: $6.17
Open: $6.54 52 Wk Low: $4.31



 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 1
 Employees 20
 Revenues (TTM) (Millions $) 17
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Precipio Inc
Precipio Inc. is a healthcare company that principally operates in the United States. The company focuses on providing diagnostic services and products for the oncology field. Precipio offers a range of services including molecular diagnostics, liquid biopsy, and cytogenetics. They utilize advanced technologies and techniques to provide accurate and precise diagnoses to healthcare providers and patients. Precipio's mission is to improve patient outcomes by delivering high-quality diagnostic solutions for cancer-related conditions.


   Company Address: 4 Science Park New Haven 6511 CT
   Company Phone Number: 787-7888   Stock Exchange / Ticker: NASDAQ PRPO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
GH        1.83% 
MYGN   -1.27%    
NEO   -9.56%    
VCYT   -1.68%    
• View Complete Report
   



Shares

Precipios Bold Shift in Executive Compensation: Performance-Driven Awards Redefine Industry Standards

Published Thu, Jan 16 2025 10:00 PM UTC

In a notable departure from traditional equity compensation structures, Precipio Inc. has announced a strategic shift in how they incentivize senior management. In a press release dated October 8, 2024, the company revealed that it will now grant performance-based awards linked to the stock price instead of traditional, time-vested Employee Stock Option Plans (ESOPs). This i...
Product Service News

Precipios Innovative Advances in Cancer Diagnostics Set a New Standard for Patient Care

Published Tue, Oct 8 2024 2:00 PM UTC

As the landscape of cancer diagnostics continues to evolve, Precipio, Inc. has positioned itself at the forefront of innovative testing solutions. The company, known for its specialty diagnostics focused on hematologic cancers, recently announced the expansion of its Bloodhound MPN panel to include CALR mutation subtyping. This development promises significant enhancements i...
Stock Market Announcement

Precipio Announces Employee Stock Option Plan Repricing: A Strategic Move to Drive Value for Employees and Shareholders,

Published Fri, Sep 6 2024 8:00 PM UTC

Precipio Announces Employee Stock Option Plan Repricing: Analysis and Impact on Shareholders
On (date), Precipio Inc. announced the repricing of their Employee Stock Option Plan, outlining the rationale behind this decision and detailing its potential impact on shareholders. With a total of 1.463543 million shares outstanding and a current price per share of $6.3, this m...
Stock Market Announcement

ABC Corporation Set to Make Waves at Rescheduled Shareholders Meeting on June 21

Published Thu, Jun 13 2024 8:00 PM UTC

The highly anticipated shareholders meeting for ABC Corporation has been rescheduled to Friday, June 21 at 9 a.m. Eastern Time. This meeting promises to be a significant event for the company and its investors, as important decisions are set to be made.
The rescheduling of the meeting has generated much speculation and anticipation among shareholders and industry analyst...
Stock Market Announcement

Precipio, Inc. Shares Update on Business Matters, Shows Promising Stock Performance

Published Wed, Jun 12 2024 1:00 PM UTC

Precipio Provides Insightful Status Update on Current Business Matters
NEW HAVEN, Conn., June 12, 2024 - Precipio, Inc. (NASDAQ: PRPO), a specialty cancer diagnostics company, recently shared important updates with its shareholders regarding various business matters as the company approaches the mid-year mark. With 1.425942 million shares outstanding and a current price ...






Precipio Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com